Flamingo Pharmaceuticals Ltd. is recognized as “Export House" by Indian government. This is a distinction conferred upon only selected companies with proven track record in the international market. Dealing in formulations and pharmaceutical products, Flamingo spans its presence in all continents across the globe.
Asia Asia is the largest continent in the world in terms of its size and account for 60% of the world’s population. Owing to its extensive size, the continent can be further fragmented into smaller regions on the basis of its very diverse cultures, races and ethnicities. Asian continent is also home to some of the world’s largest pharmaceutical markets like Japan (in terms of value), India & China (in terms of units).
Flamingo began spreading its wings within the Asian continent since 90’s. Some of the key markets in Asia where Flamingo has impregnable presence are:
·Cambodia (presence since 1998): Flamingo is on the verge of establishing strong presence in this market; with core competency area of Anti-infective & Gastroenterologicals. The strong representation in this market has been made through team of medical professionals & managers.
·Sri Lanka (presence since 1997): Flamingo has already established strong presence in this fiercely competitive market with a product basket that includes anti-infective / cardiovascular / NSAID’s /anti-diabetics. Flamingo has a strong representation in this market.
·Myanmar(presence since 1998): Strong presence through team of medical professionals & managers.
·Philippines (presence since 1998): Flamingo is one of the leading companies in Philippines with wide range of product basket.
·Vietnam (presence since 1997): Product basket includes almost all therapeutic segments.
·Hong Kong (presence since 2002): Hong Kong boasts a small but important market for Flamingo products
Africa Flamingo made its presence felt in Africa in 1990. Over the years, it has emerged as a pharmaceutical major in the continent with operations spreading out across 19 markets. Flamingo has dominated the African region in almost all therapeutic segments. By consistently introducing a wide range of products in different therapeutic specialties Flamingo has succeeded in expanding its product basket. Its state-of-the-art manufacturing facilities have been certified for Good Manufacturing Practices [GMP] confirming to international standards by competent regulatory authorities of Zimbabwe, Sudan and Uganda.
Some of the key markets are:
·Kenya (presence since 1990): Flamingo has already established strong presence in this fiercely competitive market with a product basket that includes Anti-infective / Cardiovascular / NSAID’s /Anti-diabetics. Flamingo has a strong representation in this market through its team of medical professionals and managers.
·Uganda(presence since 1997): On the verge of establishing strong presence. Core competency area is Anti-infective & Gastroenterologicals. Flamingo has strong representation through its team of medical professionals & managers.
·Ethiopia(presence since 1998): Strong presence through team of medical professionals & managers.
Other markets of Africa where Flamingo has been making its mark are Zambia, Cameroon, Republic of Guinea, Ivory Coast, Burkina Faso, Togo, Senegal, Congo and Tanzania
West Africa
Ivory Coast - Considered one of the largest pharmaceuticals markets in French speaking West Africa, Flamingo is one of the early Indian companies to enter Ivory Coast.
The company is also present in the surrounding Franco-phone (French speaking) countries of Benin, Togo, Burkina Faso, Senegal, and Cameroon with B-Ferric syrup & Red-Iron syrup as its fastest moving products
Central and South America
Central America countries has good potential for pharmaceuticals business which was identified long back by Flamingo & marked its presence a since 5 years. Today in countries like Costa-Rica, Flamingo is name to be reckoned with as one of the largest suppliers to government institutions with 51 product registrations.
·Apart from Costa-Rica, Flamingo has marked its strong presence in Guatemala, with 42 product registrations / Honduras, with 46 product registrations / El-Salvador with 41 product registrations / Nicaragua, with 26 product registrations.
·Guyana: Presence in Guyana since 1996, with 25 products registrations & Vigorix forte syrup as one of the fastest moving product.
·Albania: Presence in Albania since 2001 with 7 products registrations.
Caribbean Islands
·Haiti / Dominican Republic: Flamingo has made a strong mark in Haiti with 113 product registration & Dominican Republic with 103 product registrations, in various therapeutic segments. The presence of Flamingo in Haiti & Dominican Republic is more then a decade & being represented by team of sales professionals.
Commonwealth of Independent states (CIS)
·Ukraine: Presence since 2001. Flamingo is establishing its presence in this highly competitive market with a product basket that includes Anti-infective / Cardioasculars/ Nsaid's/ Gastri-Intestinals, Flamingo has a strong representation through its team of medical professionals and managers.
Australia – New Zealand
Flamingo is building its strong presence in this market since 1998 through various tender participations for countries like Fiji Islands, Solomon Islands and treading tie-ups in New Zealand. Product basket involves almost all therapeutic drugs
Tender Participations
Flamingo actively participates in the various tenders raised by various international health organizations like WHO, and hospitals. Flamingo has also partnered with various organizations like Missionpharma who supply WHO pharmaceuticals and medical products to governments, hospitals, United Nation agencies and NGOs in developing countries.
Other tenders in which Flamingo actively participate are from UNOPS, International Red Cross etc,
